Poor Blood Sugar Control Linked to Higher Infection Risk After Stimulator Surgery

Poor Blood Sugar Control Linked to Higher Infection Risk After Stimulator Surgery

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published May 26, 2026 | Category: Pain Medicine

Diabetes is a known risk factor for infection after many types of surgery. But there are no agreed blood sugar targets for patients having spinal cord stimulators or other neuromodulation implants. A 2025 study in Pain Physician looked at which diabetes-related factors predicted infection after these procedures.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors reviewed neuromodulation surgeries at a large cancer center from October 2019 to July 2024. They looked at diabetes type, HbA1c, blood sugar around the time of surgery, insulin use and other factors, and identified patients who developed surgical-site infections.

What they found

297 surgical cases were included, and 9 (3%) developed surgical-site infections. Infection was significantly more likely in patients with:

  • Diabetes of any type: about 6 times the odds of infection.
  • Type 1 diabetes: about 9 times the odds.
  • HbA1c above 7: about 8.6 times the odds compared with HbA1c below 7.
  • Blood sugar above 200 mg/dL around surgery.
  • Insulin use.

The authors call for defined blood sugar targets for patients considering neuromodulation.

Why this matters

An infected implant often has to be removed, which means more surgery and loss of a therapy that may have been working. Blood sugar is one of the few infection risk factors that can be improved before surgery, so checking and optimizing it is a practical prevention step.

Limitations

This was a single-center retrospective study with only 9 infections, so the estimates are imprecise and could be affected by other factors. A cancer center population may differ from other practices.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Check HbA1c before elective stimulator and pump implants in patients with diabetes.
  • Work with the patient's primary care or endocrine team to improve control before surgery when HbA1c is high.
  • Check blood sugar on the day of surgery, and manage levels above 200 mg/dL.

For hospitals, clinics and safety leaders

  • Add HbA1c and perioperative glucose checks to the neuromodulation pre-op pathway.

For patients and families

  • If you have diabetes, ask what your HbA1c should be before surgery, and follow your plan for blood sugar on the day of surgery.

Reference

  1. Mireles J, Huh A, Wang J, Sun X, Nalli S, Javed S, et al. Impact of Glycemic Control on Surgical Site Infections in Neuromodulation Pain Procedures: A Retrospective Analysis. Pain Physician. 2025 Nov;28(6):539-544. PMID: 41337766. PubMed: https://pubmed.ncbi.nlm.nih.gov/41337766/

This article is educational information, not legal or medical advice.

Previous
Previous

Radiofrequency Ablation Can Be Done Safely in Patients With Implanted Stimulators, With Precautions

Next
Next

Radiation-Protective Eyewear Reduced Eye Dose by Up to 83% During Epidural Blocks